| XZP-5809-TT1 Tablets in Patients With T790M Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer (NCT04622072) | Sihuan Pharmaceutical Holdings Group Ltd. | 2020-11-02 |
| Open-label Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of a Single Oral Dose of [14C]-20 mg/100 μCi Anaprazole Sodium Enteric-coated Capsule in Healthy Adult Male Subjects (NCT04476394) | Sihuan Pharmaceutical Holdings Group Ltd. | 2020-08-03 |
| Pharmacokinetic Interactions of Quadruple Therapy With Anaprazole/Amoxicilin/Clarithromycin/Bismuth (NCT04444011) | Sihuan Pharmaceutical Holdings Group Ltd. | 2020-07-01 |
| A Phase 3 Randomised Controlled Trial to Evaluate Efficacy and Safety of Anaprazole in Patients With Duodenal Ulcers. (NCT04215653) | Sihuan Pharmaceutical Holdings Group Ltd. | 2020-01-20 |
| Multiple-dose Tolerability and Pharmacokinetic Studies of Benapenem in Clinical Healthy Subjects (NCT04200261) | Sihuan Pharmaceutical Holdings Group Ltd. | 2019-12-16 |
| Janagliflozin Treat Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled With Metformin (NCT03851432) | Sihuan Pharmaceutical Holdings Group Ltd. | 2019-06-30 |
| Pharmacokinetics of Benapenem in Subjects With Renal Impairment (NCT04476407) | Sihuan Pharmaceutical Holdings Group Ltd. | 2019-06-15 |
| Janagliflozin Treat T2DM Monotherapy (NCT03811548) | Sihuan Pharmaceutical Holdings Group Ltd. | 2019-05-23 |
| Evaluate the Effects of Food on the Pharmacokinetics of Fadanafil in Healthy Subjects (NCT04467203) | Sihuan Pharmaceutical Holdings Group Ltd. | 2019-04-28 |
| A Multiple Ascending High Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects (NCT04471922) | Sihuan Pharmaceutical Holdings Group Ltd. | 2019-03-21 |
| A Study to Assess Efficacy and Safety Intravenous Benapenem in Patients With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP) (NCT04505683) | Sihuan Pharmaceutical Holdings Group Ltd. | 2018-12-13 |
| A Phase 2 Randomised Controlled Trial to Evaluate Efficacy and Safety of Anaprazole in Patients With Duodenal Ulcers. (NCT04503629) | Sihuan Pharmaceutical Holdings Group Ltd. | 2018-10-09 |
| Evaluate Safety, Tolerability and Pharmacokinetics of Fadanafil （XZP-5849）in Chinese Healthy Adult Male Subjects (NCT04312568) | Sihuan Pharmaceutical Holdings Group Ltd. | 2018-08-10 |
| A Phase I/II Study of XZP-3287 in Metastasis Solid Tumors (NCT04539496) | Sihuan Pharmaceutical Holdings Group Ltd. | 2018-05-22 |